BioCentury
ARTICLE | Company News

Cognetix, Elan deal

February 7, 2000 8:00 AM UTC

The companies will develop and commercialize through a Cognetix subsidiary Cognetix's contulakin-G (CGX-1160) conopeptide delivered through ELN's Medipad transdermal patch delivery system. ELN made an...